To study the improvement in symptoms and quality of life in patients with severe form of asthma after prescribing them a medication called extra-fine beclomethasone which reached right to the small airways
Not Applicable
- Conditions
- Health Condition 1: J989- Respiratory disorder, unspecified
- Registration Number
- CTRI/2024/02/062844
- Lead Sponsor
- Cipla Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Inclusion Criteria
1.Male and female participants more than equal to 18 years of age
2.Asthma patients uncontrolled on ICS LABA combination
3.Have been prescribed Niveoli for the very first time.
Exclusion Criteria
Exclusion criteria
1.Participants below the age of 18 years
2.Participants unable to perform spirometry or and lung oscillometry.
3.Participants not willing to provide consent to participate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method •Symptoms <br/ ><br>•Quality of life <br/ ><br>•Asthma control <br/ ><br>•Lung function test (Spirometry,Lung Oscillometer and PEFR if available) <br/ ><br>•Exacerbations and current medicationsTimepoint: Baseline, 3month, 6month
- Secondary Outcome Measures
Name Time Method •Symptoms <br/ ><br>•Quality of life <br/ ><br>•Asthma control <br/ ><br>•Lung function test (Spirometry,Lung Oscillometer and PEFR if available) <br/ ><br>•Exacerbations and current medicationsTimepoint: Baseline, 3month, 6month